Filtriraj po Last updated date SelectPoznejePredFrom - To Date Končni datum This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Rezultati (3838) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank EMA-HTA workshop on parallel scientific advice in drug development to take place tomorrow 25 November 2013NewsCorporate European SME Week - supporting a major driver of innovation 25 November 2013NewsCorporateSME Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 18-21 November 2013 22 November 2013NewsHuman Benefits of combined hormonal contraceptives (CHCs) continue to outweigh risks – CHMP endorses PRAC recommendation 22 November 2013Press releaseHumanPharmacovigilance European Medicines Agency recommends changes in use of leukaemia medicine Iclusig (ponatinib) in order to minimise risk of blood clots 22 November 2013Press releaseHumanMedicines European Medicines Agency recommends approval of new HIV medicine 22 November 2013Press releaseHumanMedicines European Medicines Agency recommends restricting use of thiocolchicoside by mouth or injection 22 November 2013Press releaseHumanMedicines European Medicines Agency recommends approval of sofosbuvir for the treatment of chronic hepatitis C 22 November 2013Press releaseCorporateMedicines European Medicines Agency advises on compassionate use of daclatasvir 22 November 2013Press releaseHumanMedicines European Medicines Agency recommends two new treatment options for tuberculosis 22 November 2013Press releaseHumanMedicines 1 … 211 212 213 214 215 Page 215 of 384 216 217 218 219 … 384
EMA-HTA workshop on parallel scientific advice in drug development to take place tomorrow 25 November 2013NewsCorporate
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 18-21 November 2013 22 November 2013NewsHuman
Benefits of combined hormonal contraceptives (CHCs) continue to outweigh risks – CHMP endorses PRAC recommendation 22 November 2013Press releaseHumanPharmacovigilance
European Medicines Agency recommends changes in use of leukaemia medicine Iclusig (ponatinib) in order to minimise risk of blood clots 22 November 2013Press releaseHumanMedicines
European Medicines Agency recommends approval of new HIV medicine 22 November 2013Press releaseHumanMedicines
European Medicines Agency recommends restricting use of thiocolchicoside by mouth or injection 22 November 2013Press releaseHumanMedicines
European Medicines Agency recommends approval of sofosbuvir for the treatment of chronic hepatitis C 22 November 2013Press releaseCorporateMedicines
European Medicines Agency advises on compassionate use of daclatasvir 22 November 2013Press releaseHumanMedicines
European Medicines Agency recommends two new treatment options for tuberculosis 22 November 2013Press releaseHumanMedicines